IBSA USA
Maribeth Morrissey is an accomplished Specialty Pharmaceutical Representative at IBSA USA, where performance includes ranking as the #1 Representative in the nation for three out of four quarters, achieving consistent market share growth, and establishing key relationships with major healthcare institutions such as Mayo Clinic and St Vincent's Hospital. Responsibilities also involve educating and selling products like Tirosint Sol and Licart to a diverse range of specialists while sharing sales strategies and coordinating regional training sessions. Prior experience includes serving as an Account Executive at Apex Home Healthcare and Elara Caring Hospice, focusing on business development and patient care in the hospice sector. Maribeth holds a Bachelor of Arts degree in Speech Communication from Kent State University.
This person is not in any teams
IBSA USA
IBSA USA is the subsidiary of IBSA Group, the largest privately owned pharmaceutical company in Switzerland. IBSA is committed to improving patient quality of life through research, innovation, and the development of effective drugs and cutting-edge technologies. IBSA USA markets two unique levothyroxine formulations in the U.S. for the treatment of hypothyroidism: Tirosint® (levothyroxine sodium) capsules and Tirosint®-SOL (levothyroxine sodium) oral solution. IBSA also markets Licart™ (diclofenac epolamine) topical system 1.3%, the only once-a-day topical nonsteroidal anti-inflammatory (NSAID) available in the U.S. to treat acute pain due to minor strains, sprains, and contusions. IBSA is focused on the health and well-being of patients and driven by the desire to bring therapeutic alternatives to as many people as possible. IBSA Group bases its philosophy on four sustainable pillars: Person, Innovation, Quality, and Responsibility. For more information about Tirosint, Tirosint-SOL, or Licart, including Full Prescribing Information, go to each brand’s respective website.